A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

Pfizer logo

Pfizer

Status and phase

Completed
Phase 3

Conditions

Diabetes Mellitus

Treatments

Drug: Inhaled Insulin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00134147
A2171018

Details and patient eligibility

About

To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

Sex

All

Ages

35 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetes mellitus Type 2
  • Failing two or more oral anti-diabetic agents

Exclusion criteria

  • Asthma, COPD
  • Smoking

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems